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Abstract
Astrocytes are integral functional components of synapses, regulating transmission and plasticity. They have also been
implicated in the pathogenesis of epilepsy, although their precise roles have not been comprehensively characterized.
Astrocytes integrate activity from neighboring synapses by responding to neuronally released neurotransmitters such as
glutamate and ATP. Strong activation of astrocytes mediated by these neurotransmitters can promote seizure-like activity
by initiating a positive feedback loop that induces excessive neuronal discharge. Recent work has demonstrated that
astrocytes express cannabinoid 1 (CB1) receptors, which are sensitive to endocannabinoids released by nearby pyramidal
cells. In this study, we tested whether this mechanism also contributes to epileptiform activity. In a model of 4-
aminopyridine induced epileptic-like activity in hippocampal slice cultures, we show that pharmacological blockade of
astrocyte CB1 receptors did not modify the initiation, but significantly reduced the maintenance of epileptiform discharge.
When communication in astrocytic networks was disrupted by chelating astrocytic calcium, this CB1 receptor-mediated
modulation of epileptiform activity was no longer observed. Thus, endocannabinoid signaling from neurons to astrocytes
represents an additional significant factor in the maintenance of epileptiform activity in the hippocampus.
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Introduction
Synaptic transmission depends on complex interactions
between presynaptic terminals, postsynaptic targets and associat-
ed astrocytes [1] that form a structure referred to as the tripartite
synapse [2,3]. When the interplay between these elements is
disrupted, the regulation of synaptic signaling breaks down.
Astrocyte to neuron communication is induced by the gliotrans-
mitters glutamate, D-serine, and ATP [4–6]. Glutamate released
by astrocytes binds to extrasynaptic neuronal NMDA receptors
entraining synchronized activity [7,8]. In the other direction,
pyramidal cells signal to astrocytes primarily by glutamate that
binds to astrocytic metabotropic glutamate receptors, although
astrocytes are also sensitive to ATP, GABA and nitric oxide [3].
Under pathological conditions, excessive activation of astrocytes
by neuronal glutamate and ATP induces paroxysmal depolar-
izations that initiate epileptiform discharge [9,10]. The aim of
our study was to examine whether activation of astrocyte CB1
receptors also plays a role in the generation of epileptiform
discharge. A number of past observations have suggested that
marijuana use may be protective against seizures [11]. The CB1
receptor exhibits the highest expression of any G protein-coupled
receptor in the brain [12], and was thought to act primarily by
depressing synaptic transmission [13,14]. Recently, however, a
study in the hippocampus showed that CB1 receptors also
mediate the activation of astrocytes [15], which resulted in
potentiated synaptic transmission [16]. Thus, CB1 signaling by
astrocytes may contribute to the pathogenesis of seizures. Indeed,
we find that in hippocampal networks communication from
neurons to astrocytes via CB1 receptors is an essential factor in
the maintenance although not the induction of epileptiform
activity. Thus, endocannabinoid signaling from neurons to
astrocytes represents a significant contribution to the mainte-
nance of ED in the hippocampus.
Methods
Ethics statement
All animal procedures were performed in accordance with Swiss
law, with strict attention given to the care and use of animals. The
protocols for our experiments were approved by the Ethics
Committee of the Veterinary Department of the Canton of Zurich
(Approval ID 41/2011).
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Hippocampal slice cultures were prepared from 6-day-old
Wistar rats as described previously [17] following a protocol
approved by the Ethics Committee of the Veterinary Department
of the Canton of Zurich (Approval ID 41/2011). Briefly,
hippocampi were dissected and individual transverse slices
(375 mm thick) were transferred to a glass coverslip, which was
placed into a test tube filled with culture medium. The tubes were
then kept in a roller drum in an incubator at 36uC. After 3–4
weeks in vitro a coverslip bearing a hippocampal slice culture was
transferred to a recording chamber on an upright microscope
(Axioscope FS, Zeiss).
Induction of epileptiform activity
4-aminopyridine (4-AP) was added to the superfusate at
100 mM, a concentration that reliably induces epileptiform
activity [18–20]. Epileptiform activity induced in organotypic
slices can be characterized according to the following three
phases [18]: 1) Epileptiform discharge begins with a sharp initial
depolarizing shift and then slowly returns to baseline. This initial
response can be taken as time zero for data analysis. 2) During
the first 30 sec of discharge, numerous high frequency/low
amplitude depolarizations (tonic-like phase) are superimposed on
a slow depolarizing shift. 3) During the following 10 min,
epileptiform events decrease in frequency but increase in
amplitude, corresponding to a clonic-like phase. These events
measured intracellularly are referred to as epileptiform discharge
(ED). They are quasi synchronous between CA1 pyramidal
neurons and also with CA3 pyramidal neurons [21]. In
extracellular recordings each epileptiform depolarization induces
an ‘‘epileptic-spike’’-like event in the field recording [22–23].
ED quantification
To quantify the number of ED events induced by 4-AP
superfusion, signals were high-pass filtered (0.05 Hz) to suppress
the slow depolarizing shift, and a threshold was set above which
ED events were registered. ED events were identified according
to their form (polarity, amplitude, and duration). Signals were
accepted as an ED if they were spontaneous (i.e. not evoked by
electrical stimulation) and if they exhibited a minimum amplitude
of 10 mV and minimum duration of 40 ms. We confirmed that
ED events were almost synchronized between CA1 pyramidal
cells (n=5, data not shown). In addition, ED recorded in a CA1
pyramidal cell was synchronized with a simultaneous event in the
field recording in CA1 stratum radiatum (n=8, Fig. 1A). ED
events were never observed in the absence of 4-AP superfusion.
Current-clamp recordings
CA1 pyramidal neurons were recorded in the current-clamp
mode of the whole cell configuration of the patch-clamp
technique (Axopatch 200B amplifier, Molecular Devices). Slices
were superfused continuously at a rate of 1–2 ml/min with
artificial cerebrospinal fluid (ACSF) equilibrated with 95% O2/
5% CO2 containing (in mM): 124 NaCl, 2.5 KCl, 26 NaHCO3,
1.25 NaH2PO4, 10 glucose, 3 CaCl2, 2 MgCl2, pH 7.4, at a bath
temperature of 34uC. Recording pipettes (3–6 MV), were filled
with an intracellular solution containing the following: 135 mM
K-gluconate, 4 mM KCl, 10 mM HEPES, 10 mM Na2-phos-
phocreatine, 4 mM Mg-ATP, 0.3 mM Na-GTP, pH 7.2, 291–
293 mOsm. Recordings were performed continuously to record
the entire duration of epileptic-like activity. Electrophysiological
data were acquired and analyzed with pClamp 9.0 software.
Signals were analog-filtered at 10 kHz and sampled at 100–
300 kHz.
Calcium imaging
All calcium imaging experiments were performed following
multi-cell bolus loading in the CA1 area of the calcium indicator
Oregon Green BAPTA-1 (OGB-1 AM, 50 mg, Molecular Probes)
dissolved in DMSO plus 20% Pluronic F-127 (BASF, Florham
Park, NJ) to stain populations of cells. OGB-1 AM was diluted to a
final concentration of 1 mM in normal rat Ringer solution
containing (mM) 135 NaCl, 5.4 KCl, 5 HEPES, 1.8 CaCl2,a t
pH 7.2, and was pressure injected into the pyramidal layer of the
CA1 region through a patch pipette. Two-photon calcium-
imaging was performed ,30 min after dye injection using a
custom-built AOD two-photon microscope as described in [24] at
850-nm wavelength provided by a mode-locked Ti:sapphire laser
system (Cameleon Ulstra II, Coherent) and a Pockels Cell
(Conoptics), which allowed regulation of laser beam intensity to
minimize bleaching. In all experiments, a water-immersion
objective (406 LUMPlanFl/IR, 0.8 NA, Olympus) was used.
Before drug application, 120 baseline images with a 2 Hz frame
rate were taken over 2 minutes. Imaging was then continued at
2 Hz during 4-AP perfusion (100 mM) for 15 minutes. Imaging
traces show the relative change in fluorescence (DF/F).
Drugs
Concentrated stock solutions of drugs were prepared in distilled
water or dimethylsulfoxide (not exceeding a final concentration of
0.02%), stored at -20uC in single-use aliquots, thawed and diluted
in ACSF immediately before use. Picrotoxin, mefloquine, and
carbenexolone and 4-AP were purchased from Sigma, AM251,
and MPEP (2-Methyl-6-(phenylethynyl)pyridine hydrochloride)
from Tocris (Bristol, UK), and tetrodotoxin (TTX), NBQX (2,3-
Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7 –sulfon-
amide), CPCCOEt, WIN55212, MRS 2179 from abcamBio-
chemicals (Cambridge, UK), BAPTA from Molecular Probes).
CGP62349 was kindly provided by Novartis AG (Basel, Switzer-
land).
Statistics
Data are presented as mean percentage of control 6 SEM.
Unpaired Student’s t-tests were used to compare responses under
the various conditions. When necessary, a non-parametric
statistical hypothesis test (Mann-Whitney U-test) was used to
compare several samples of independent observations.
Results
Induction of epileptiform discharge (ED)
As approximately 70% of adult patients diagnosed with mesial
temporal lobe epilepsy do not respond to drug treatment [25], we
chose an in vitro preparation of rat hippocampal organotypic slices
are exposed to 4-AP previously shown to be resistant to standard
antiepileptic drugs [19]. We first confirmed that 4-AP reliably
induces epileptiform discharge (ED) in rat hippocampal slice
cultures under our experimental conditions. Whole cell patch
clamp recordings from CA1 pyramidal cells showed that
application of 4-AP (100 mM) for at least 15 min induced
epileptiform discharge (ED) in 39 out of 41 slice cultures tested
(Fig. 1A). As reported previously, cells responded to 4-AP with an
initial tonic discharge as observed in field recordings [19], or a
marked depolarization of 30.2614.6 mV. This initial event was
followed by epileptiform bursting that continued for
10.863.3 min. (Fig. 1A, B), also referred to as recurrent clonic-
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PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e37320Figure 1. Astrocytes participate in the maintenance of epileptiform activity in CA1. A, A field recording in the CA1 area and a patch-clamp
recording from a CA1 pyramidal cell show a typical initial depolarization event followed by epileptiform discharge (ED) in response to continuous
application of 4-AP (100 mM). The insets show examples of individual EDs taken from the left traces at an expanded time base. B, Averaged time
course of ED frequency following the initial depolarization as measured with patch-clamp recording (n=23). C, Two-photon fluorescence imaging in
hippocampal organotypic slice cultures during ED showing co-activation of neuronal and glial networks. Top right shows an overlaid image with
neurons (green) loaded with OGB-1 and astrocytes (red) with sulforhodamine 101. Traces show the calcium rise both in neurons and astrocytes
during 4-AP-induced epileptiform activity. Below are images of cellular calcium levels before (left) and during (right) epileptiform activity. Scale
bar=30 mm. D, Time course of fluorescence changes in CA1 pyramidal cells and in astrocytes during 4-AP superperfusion (n=164 neurons and 146
astrocytes in 8 slice cultures). The plotted points represent averages of the mean cellular responses for each slice. E, Chelating calcium with
intracellular BAPTA in astrocytes decreases the frequency of ED recorded in a CA1 pyramidal cell. Top: Images show a patch-clamp pipette
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a duration of 62.463.4 ms that exceeded 10 mV in amplitude
(Fig. 1A) and if discharge threshold is reached, one to three action
potentials were frequently elicited.
Activity of neurons and astrocytes during ED
We examined whether astrocytes are also activated during ED
by using two-photon fluorescence imaging to measure intracellular
calcium signals. The membrane permeable calcium indicator
Oregon Green Bapta 1-AM (OGB1-AM, 1 mM) was injected
locally into slice cultures, and sulforhodamine 101 (1 mM) was
applied to identify astrocytes [26]. Comparison of the OGB1-AM
signal with the sulforhodamine-labeled cells in overlaid images
indicated that virtually all the astrocytes in a visualized region of
interest responded with an increase in calcium during ED (Fig. 1C).
Calcium increases were induced in almost all neurons superfused
with 4-AP (9863%, n=164 cells, n=8 slices) and most astrocytes
(85615%, n=146 cells, n=8 slices). The amplitude of the
calcium signal in neurons was delta F/F: 160.1 at 1–2 min and
0.6360.12 at 5 min and in astrocytes it was delta F/F: 0.460.04
at 2 min and 0.1260.03 at 5 min (Fig. 1D). The duration of
elevated calcium signals in neurons corresponded to the time
course of ED measured in patch-clamp recordings from CA1
pyramidal cells (Fig. 1B, D).
Role of astrocytes in ED initiation
To determine whether the calcium elevations in astrocytes
represent a correlative response or a causal determinant of ED, the
effect of inhibiting calcium signaling in astrocyte networks was
evaluated. Astrocytes were patched in the stratum radiatum of
CA1 close to the stratum pyramidale. Calcium was chelated in a
targeted astrocyte patched with a pipette containing BAPTA
(40 mM) as well as the fluorescent dye Alexa 488, which allowed
us to monitor diffusion of the pipette contents. Cells were
considered to be astrocytes based on their negative resting
potential (29064 mV), their low membrane resistance
(1865M V, n=8), and the absence of action potentials in
response to current injection. By depolarizing the patched
astrocyte, gap junctions are opened, resulting in the diffusion of
the pipette contents to neighboring astrocytes in the syncytium
[27]. When a recording was now obtained from a neighboring
CA1 pyramidal cell, the frequency of events during ED was
significantly lower than that measured in a CA1 pyramidal cell in
which an adjacent astrocyte was patched with a pipette containing
the standard recording solution without BAPTA (ED decreased by
5866%, n=4, p,0.05, after 8–10 min, Fig. 1E). Similarly,
blocking gap junctions with carbenoxolone (100 mM), reduced
the duration of epileptiform activity, as reported previously [27],
but not with mefloquine (Fig. 1F).
Although these experiments show that astrocytes significantly
contribute to ED, their activity did not appear to modulate the
initiation of the 4-AP-induced discharge. To address this issue in
more detail, the effects of several known inhibitors of glial function
on the probability of ED initiation in response to 4-AP was
quantified. Carbenoxolone (100 mM), a blocker of neuronal as well
as glial gap junctions, did not alter the probability of initiation of
ED (0 out of 5 slices), nor did mefloquine (25 mM, 0 out of 5 slices),
a blocker primarily of neuronal gap junctions composed of Cx36
and Cx50 [28,29] (Fig. 2A). A combination of antagonists reported
to inhibit neuroglial interactions by blocking P2Y1 (MRS 2179,
4 mM), and mGlu5 (MPEP 10 mM) receptors [8,30,31,32] also
failed to modify initiation of ED (0 out of 4 slices, Fig. 2A).
Initiation of ED was, however, prevented when synaptic trans-
mission was inhibited with TTX (1 mM) (4 out of 4 slices,
p,0.001, ANOVA), significantly reduced by NBQX (50 mM) (4 of
6 slices, p,0.001) but less affected by the NMDAR antagonist
AP5 (40 mM) (2 out of 8 slices, p.0.05; Fig. 2A).
Role of astrocytes in ED maintenance
As the initiation of ED appears to be independent of astrocyte
activation, we then tested whether the maintenance of recurrent
discharge is affected by inhibitors of neuroglial communication.
Neurons can activate astrocytes by releasing glutamate ([33,34]
that acts mainly on mGluR5 [8] and ATP that acts on P2Y1
receptors ([30–32]. However, neither the selective blockade of
P2Y1 receptors with MRS 2179 (4 mM) (6615%, n=3, p.0.1),
nor the combined blockade of P2Y1 and mGlu5 receptors (MRS
2179, 4 mM+MPEP, 10 mM; 3066%, n=4, p,0.001) reduced the
frequency of ED events (Fig. 2B, C). In fact, the addition of MPEP
to the superfusate led to an increase in ED frequency, as was also
reported previously [10] during interictal activity induced by
picrotoxin/zero-magnesium in acute slices of entorhinal cortex.
Role of interneuronal and astrocytic CB1R in ED
maintenance
Recent findings demonstrate that astrocyte signaling is also
sensitive to endocannabinoids released from neighboring neurons
[15,16]. We therefore tested the effect of adding AM 251 (4 mM), a
CB1 receptor antagonist, to the superfusate containing the
antagonists for CB1, P2Y1 and mGlu5 receptors. Neither this
cocktail nor the CB1 antagonist alone, inhibited epileptiform
discharges initiation (0 out of 5 slices, Fig. 2A). But instead of
increasing ED, this solution significantly reduced their frequency
(28565%, n=5, p,0.001; Fig. 2D, E). As these results indicate
that activation of hippocampal CB1 receptors represents a
prominent determinant in the entrainment of recurrent ED
induced by 4-AP, we focused the remainder of our experiments on
characterizing the mechanisms involved in endocannabinoid
signaling during ED. Selective blockade of CB1 receptors with
AM 251, diminished calcium signals in CA1 pyramidal neurons
(by 4364%, n=81, p,0.05, 1–4 min, Fig. 3A, B). This inhibition
was markedly greater in astrocytes than in neurons with a decrease
in the frequency of ED events by 95611% (n=74, p,0.001
Mann-Whitney U-test). This difference in response between
neurons and astrocytes suggest that activation of astrocytes via
CB1 receptors is particularly pronounced during epileptiform
activity. A comparable effect on 4-AP-induced ED in response to
blockade of CB1 receptors was observed in current clamp
approaching the CA1 stratum radiatum (left), an astrocyte patched with the pipette containing BAPTA (40 mM) and the fluorescent dye Alexa 488
(middle), and the diffusion of the fluorescent marker throughout a small network of astrocytes following depolarization (1 nA injection) to open gap-
junctions (right). Bottom left: representative current clamp recordings from a CA1 pyramidal cell during ED when a neighboring astrocyte was
injected with control intracellular solution (black trace) or with BAPTA (gray trace). Sample activity at expanded time base is shown at right. Bottom
Right: Mean ED frequency at two time points after initiation of ED for CA1 pyramidal cells with a neighboring astrocyte filled with control intracellular
solution versus a 40 mM BAPTA intracellular solution (n=4). F, current-clamp traces recorded from single CA1 pyramidal cells in 4 different slice
cultures showing ED activity in control or after incubation for three hours with two antagonists of connexins, carbenoxolone (100 mM) and
mefloquine (25 mM).
doi:10.1371/journal.pone.0037320.g001
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Fig. 3C, D, E). Interestingly, blockade of CB1 receptors not only
attenuated ED, but also revealed the presence of repetitive, large
amplitude inhibitory post-synaptic potentials. This observation
suggests that the intense activity generated by 4-AP leads to
depolarization-induced suppression of inhibition (DSI), as de-
scribed previously [35], and that the inhibition of DSI by blocking
CB1 receptors [36] allows GABAergic synaptic signaling to
reemerge.
As CB1 receptors in the hippocampus are expressed not only by
astrocytes but also by the CCK-positive subpopulation of
GABAergic interneurons [14], we re-examined the effect of CB1
receptor blockade on ED frequency under conditions where
interneuron signaling was prevented by inhibiting GABAA
(picrotoxin) and GABAB receptors (CGP62349). Under these
conditions, blockade of CB1 receptors with AM 251 still led to a
significant reduction in ED (4-AP+CGP+Picro+AM251, n=6,
compared to 4-AP+CGP+Picro, n=5; decrease of 22365%
p,0.05) although this effect was much less than with interneuron
signaling intact (28965%; Fig. 3F). Thus, both astrocytes and
interneurons are involved in the CB1 receptor-mediated mainte-
nance of ED. To further confirm a contribution from astrocytes to
the CB1 receptor-dependent enhancement of ED maintenance,
we quantified the effects of CB1 receptor blockade after both
interneuron and astrocyte signaling were inhibited with GABA
antagonists and intracellular BAPTA, respectively. As expected,
application of AM251 now no longer affected ED (216617%,
n=5, p.0.5; Fig. 3G).
Figure 2. The duration but not the initiation of ED is reduced following disruption of neuroglial interactions. A, Compounds reported
to disrupt neuroglial and astrocyte coupling do not modify the initiation of ED in response to 4-AP. The probability of ED initiation was not changed
either by antagonists for gap junctions or by a solution that inhibits neuroglial interactions consisting of MRS 2179 (4 mM) to block P2Y1 receptors
and MPEP (10 mM) to block mGluR5. The probability of ED initiation was not changed either by a cocktail containing antagonists for P2Y1R, mGluR5
and CB1R (AM251, 4 mM) or CB1R antagonist alone. But ED initiation is prevented when synaptic transmission is blocked with TTX (1 mM), or reduced
when ionotropic glutamate receptors are blocked with NBQX (50 mM). B, Application of antagonists for P2Y1 and mGlu5 receptors increases the
frequency of ED induced by 4-AP, while MRS alone has not effect. C, Mean ED frequency 4–6 and 8–10 minutes after initiation. D, E, Addition of
AM251 to the MRS 2179 and MPEP solution significantly reduces ED frequency.
doi:10.1371/journal.pone.0037320.g002
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The concept of the tripartite synapse in which astrocytes exert
an essential function in controlling synaptic transmission is now
well established [5]. In the case of excessive neuronal discharge
generated by epileptiform bursts a commensurate powerful
activation of astroglial networks is induced [27]. A recent study
has shown that astrocytes respond primarily to glutamate and ATP
during neuronal hyperactivity, which induces them, in turn, to
release glutamate onto neurons resulting in a positive feedback
loop that amplifies the initiating neuronal event [10]. Our results
in an in vitro model of drug resistant epilepsy show that
endocannabinoid signaling from neurons to astrocytes represents
Figure 3. CB1 receptors expressed by astrocytes contribute significantly to maintenance of ED in CA1. A, Two-photon fluorescence
calcium imaging of CA1 cells during 4-AP perfusion of the slice. Fluorescence signals from neurons and astrocytes during 4-AP in the presence or
absence of the CB1 receptor antagonist AM251 (4 mM). The plotted points represent the averages of the responses for each individual cell. B, Blocking
CB1 receptors significantly reduced integrated area of calcium induced fluorescence measured 1–4 min after ED initiation. This inhibition was
markedly particularly important in astrocytes (p,0.001 Mann-Whitney U test) C, Similarly, average time course show that ED in CA1 pyramidal cells
recorded in current-clamp mode is reduced in the presence of the CB1 antagonist AM251. D, Representative traces for data shown in C. E, Mean ED
frequency at two time points after initiation of ED for CA1 pyramidal cells show that the reduction induced by AM251 is highly significant. F, In the
presence of GABAA and GABAB receptor antagonists to block interneuron signaling, blocking CB1 receptors still results in a significant reduction in ED
but much less effective in reducing ED frequency. G, When astrocyte signaling is inhibited by BAPTA injection (40 mM) under conditions where
GABAergic transmission is blocked, the blockade of CB1 receptors no longer reduces 4-AP-induced ED.
doi:10.1371/journal.pone.0037320.g003
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epileptiform activity in the CA1 hippocampal network. We found
that blocking CB1 receptors during 4-AP-induced epileptiform
activity markedly diminished calcium responses in astrocytes and
the frequency of ED recorded in CA1 pyramidal cells. However,
CB1 receptor blockade did not reduce the probability of initiation
of epileptiform activity. Our findings are consistent with the
expression of CB1 receptors in hippocampal astrocytes, and the
demonstration that these receptors are targeted by endocannabi-
noids released from pyramidal cells [15]. Activation of astrocytic
CB1 receptors then induces release of calcium from intracellular
stores triggering glutamate release, which potentiates synaptic
transmission in neighboring neurons [15,16]. However in the
present study we did not discriminate between glutamate released
by astrocytes and glutamate released by neurons during the
epileptic-like activity. To date, there are no pharmacological tools
that specifically inhibit glutamate release from astrocytes without
affecting glutamate release from neurons.
A more prominent action of endocannaboids in the hippocam-
pus is DSI of cholecystokinin-positive interneurons [14], leading to
reduced release of GABA [37], and also depression at excitatory
glutamatergic terminals but, in the hippocampus, to a much lesser
extent [38]. In our in vitro model the disinhibition resulting from
endocannabinoid-mediated DSI of interneurons represents a
major contribution to the maintenance of epileptiform activity
(Fig. 3E versus Fig. 3F). Nevertheless, when GABAergic signaling
by interneurons was blocked, a significant endocannabinoid-
dependent response mediated by astrocytes remained (Fig. 3G).
Thus, endocannabinoid signaling from pyramidal cells to both
astrocytes and CB1 receptor-positive interneurons is involved in
the maintenance of epileptiform activity in our experiments. In
this respect, it is interesting to note that in control conditions, a
very strong temporal and spatial correlation was observed between
endocannabinoid-mediated DSI and astrocytic calcium elevation
in response to neuronal discharge [15].
Additional mechanisms through which astrocytes may contrib-
ute to epileptiform activity include the modulation of neurovas-
cular coupling and of glucose trafficking in response to the intense
activity during seizures [10,27]. Furthermore, the intense neuronal
activity generated by epileptiform bursts increases the functional
extent astrocytic networks, an effect mediated by gap junctions
[27]. We also found evidence for an involvement of gap junction
signaling among astrocytes in the maintenance of epileptiform
activity.
Our main finding, that endocannabinoids promote the main-
tenance of epileptiform activity may seem surprising in light of
several earlier investigations. In the in vitro kainate model of
epileptogenesis, it appears that contrary to control conditions [38]
endocannabinoids induce proportionally greater inhibition of
glutamate release from pyramidal cells than GABAergic release
from interneurons, thus having a net suppressing effect on seizure-
like activity [39]; [40]. Similarly, in a low magnesium slice model
of hippocampal seizures, activation of CB1 receptors decreased the
frequency of ED [41]. In in vivo studies, stimulation of CB1
receptors had anticonvulsant effects in the electroshock model to
evoke seizures in mice [42] and in the rat pilocarpine model of
epilepsy [43]. And in rat neonates, blocking CB1 receptors
resulted in epileptic activity [44]. In contrast, chronic blockade of
CB1 receptors was found to reduce the seizure threshold induce by
hyperthermia [45]. Also, studies in humans have reported both
pro and anticonvulsive effects of smoking marijuana in subject
with epilepsy [11], whereas other work suggests that activation of
CB1 receptors does not alter the propensity for seizures [46]. The
discrepancies between these results obtained in animal and human
studies suggest that the modulation CB1 receptors has complex
actions, and perhaps opposite effects on neuronal versus glial
network activity. Activation of CB1 receptors may be useful in
counteracting the initiation of seizures by promoting depolariza-
tion-induced suppression of excitation. However, as shown by our
data, activation of CB1 receptors expressed by astrocytes triggers
calcium signaling in glial networks that in turn can amplify
responses of excitatory neurons and thus enhance the maintenance
of epileptiform discharge.
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